Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Milella

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|September 10, 2004
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedulesE Terzoli, C Nisticò, A Fabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)G Palmieri, G Merola, P Federico, et al.
Cell Death & Disease|December 11, 2012
Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cellsV Folgiero, S E Di Carlo, G Bon, et al.
Breast Cancer Research and Treatment|October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal womenM Milella, C Nisticò, V Ferraresi, et al.
Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.
Scientific Reports|March 9, 2022
New insights on commemoration of the dead through mortuary and architectural use of pigments at Neolithic Çatalhöyük, TurkeyE M J Schotsmans, G Busacca, S C Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2022
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of VeronaS Zanelli, E Fiorio, I Zampiva, et al.
Leukemia|November 9, 2011
MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Breast Cancer Research and Treatment|June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patientsC Nisticò, C Garufi, M Milella, et al.
Leukemia|July 18, 2024
Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Journal of Experimental & Clinical Cancer Research : CR|September 10, 2004
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedulesE Terzoli, C Nisticò, A Fabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)G Palmieri, G Merola, P Federico, et al.
Cell Death & Disease|December 11, 2012
Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cellsV Folgiero, S E Di Carlo, G Bon, et al.
Breast Cancer Research and Treatment|October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal womenM Milella, C Nisticò, V Ferraresi, et al.
Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.
Scientific Reports|March 9, 2022
New insights on commemoration of the dead through mortuary and architectural use of pigments at Neolithic Çatalhöyük, TurkeyE M J Schotsmans, G Busacca, S C Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2022
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of VeronaS Zanelli, E Fiorio, I Zampiva, et al.
Leukemia|November 9, 2011
MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Breast Cancer Research and Treatment|June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patientsC Nisticò, C Garufi, M Milella, et al.
Leukemia|July 18, 2024
Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Pageof 13